Trial intelligence / Profile preview

Comparison of ARNI vs Amlodipine in Hypertension with LVH

NCT04929600Phase 4Unknown

Sponsor
Shanghai Jiao Tong University School of Medicine
Start
Nov 2021
Primary completion
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sacubitril + valsartan in hypertension (HTN), left ventricular hypertrophy (LVH), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.

02

Drugs

sacubitril + valsartan
03

Conditions

hypertension (HTN)left ventricular hypertrophy (LVH)

Beyond the preview

Go deeper on NCT04929600.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04929600.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call